Abstract:Studies in hematopoietic aging have shown that classically defined, highly purified hematopoietic stem cells (HSCs) increase in number but have impaired function and exhibit myeloid skewing. However, we identified a cycling population of HSCs in young mice that appear to be preferentially lost during standard HSC isolations and therefore poorly represented within the purified HSC population. Here, we sought to determine how aging may alter this total HSC population in unseparated murine whole bone marrow (WBM). In limit dilution competitive bone marrow transplantation, we found that, at 6 months post-transplant, old (24-26-mo-old) WBM had a 4-fold increase in functional HSCs compared to young (6-8-wk-old) WBM. Unlike purified old HSCs, old WBM showed only minimal myeloid skewing (myeloid: 26%±11% of old donor peripheral blood vs.19%±16% of young donor peripheral blood; average percent donor peripheral blood ± SD; n=26 mice). Interestingly, in two experiments, old WBM retained full engraftment capacity in secondary transplant with no myeloid skewing, while in a third experiment, old WBM engraftment was significantly decreased when compared to young WBM (15%±9% vs. 57%±3%, respectively; average% donor chimerism ± SD), and exhibited clear myeloid skewing (myeloid: 65%±7% of old donor peripheral blood vs. 20%±10% of young donor peripheral blood; 4-5mice/grp/exp). These data suggest that only those old HSCs in unseparated WBM with high engraftment capacity may retain youthful myeloid/lymphoid ratio patterns. Preliminary data in female mice were similar, showing that HSCs were 7.8-fold increased in old vs. young WBM, retained repopulation capacity in secondary transplantation, and displayed no significant myeloid skewing. These patterns of robust reconstitution without myeloid skewing by old WBM are quite distinct from those of the classically-defined, purified old HSCs, suggesting the presence of a unique HSC population in WBM with differential susceptibility to aging. Further study of this population may yield novel insights into the effects of aging on HSC function and lineage fate decisions and facilitate innovative rejuvenation strategies. Studies in hematopoietic aging have shown that classically defined, highly purified hematopoietic stem cells (HSCs) increase in number but have impaired function and exhibit myeloid skewing. However, we identified a cycling population of HSCs in young mice that appear to be preferentially lost during standard HSC isolations and therefore poorly represented within the purified HSC population. Here, we sought to determine how aging may alter this total HSC population in unseparated murine whole bone marrow (WBM). In limit dilution competitive bone marrow transplantation, we found that, at 6 months post-transplant, old (24-26-mo-old) WBM had a 4-fold increase in functional HSCs compared to young (6-8-wk-old) WBM. Unlike purified old HSCs, old WBM showed only minimal myeloid skewing (myeloid: 26%±11% of old donor peripheral blood vs.19%±16% of young donor peripheral blood; average percent donor peripheral blood ± SD; n=26 mice). Interestingly, in two experiments, old WBM retained full engraftment capacity in secondary transplant with no myeloid skewing, while in a third experiment, old WBM engraftment was significantly decreased when compared to young WBM (15%±9% vs. 57%±3%, respectively; average% donor chimerism ± SD), and exhibited clear myeloid skewing (myeloid: 65%±7% of old donor peripheral blood vs. 20%±10% of young donor peripheral blood; 4-5mice/grp/exp). These data suggest that only those old HSCs in unseparated WBM with high engraftment capacity may retain youthful myeloid/lymphoid ratio patterns. Preliminary data in female mice were similar, showing that HSCs were 7.8-fold increased in old vs. young WBM, retained repopulation capacity in secondary transplantation, and displayed no significant myeloid skewing. These patterns of robust reconstitution without myeloid skewing by old WBM are quite distinct from those of the classically-defined, purified old HSCs, suggesting the presence of a unique HSC population in WBM with differential susceptibility to aging. Further study of this population may yield novel insights into the effects of aging on HSC function and lineage fate decisions and facilitate innovative rejuvenation strategies.

Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity

Rejuvenating an old immune system

Age-associated imbalance in immune cell regeneration varies across individuals and arises from a distinct subset of stem cells

Anti-ageing antibodies revive the immune system

The Benjamin Button effect on stem cells: Reversing the clock on aging immunity

How to make an old immune system young again

High-dimensional single cell mass cytometry analysis of the murine hematopoietic system reveals signatures induced by ageing and physiological pathogen challenges

Immunoaging induced by hematopoietic stem cell aging.

Aged hematopoietic stem cells are refractory to bloodborne systemic rejuvenation interventions

3079 – MURINE WHOLE BONE MARROW MAY CONTAIN A NONCONVENTIONAL POPULATION OF LONG-TERM MULTI-LINEAGE REPOPULATING CELLS WITH ALTERED SUSCEPTIBILITY TO AGING

An aged immune system drives senescence and ageing of solid organs

Hallmarks of the aging T‐cell system

BCL-Xl Driven Accumulation of Dysfunctional Mitochondria in Aged Stromal Cells Impairs the Haematopoietic Stem Cell Response to Stress

Large-Scale Clonal Analysis Resolves Aging of the Mouse Hematopoietic Stem Cell Compartment

Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice

Regeneration of Dendritic Cells in Aged Mice

Potential of Mesenchymal Stem Cells in the Rejuvenation of the Aging Immune System

Mechanisms and rejuvenation strategies for aged hematopoietic stem cells

Reducing functionally defective old HSCs alleviates aging-related phenotypes in old recipient mice

Aging is associated with functional and molecular changes in distinct hematopoietic stem cell subsets

Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination